Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1290/week)
    • Manufacturing(559/week)
    • Energy(392/week)
    • Technology(1135/week)
    • Other Manufacturing(384/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

DelMar Pharmaceuticals Inc.

Jun 22, 2020
DelMar Pharmaceuticals Presents Positive Interim Data on VAL-083 Demonstrating Favorable Outcomes in Both Newly- Diagnosed and Recurrent GBM at the AACR Virtual Annual Meeting II
Jun 10, 2020
DelMar to Acquire Adgero Biopharmaceuticals, Expands Late-Stage Oncology Pipeline
Jun 04, 2020
Global Coalition for Adaptive Research (GCAR) Selects DelMar Pharmaceuticals' VAL-083 to Participate in the GBM AGILE Pivotal Study, an Adaptive Clinical Trial Platform in Glioblastoma Multiforme
Jun 01, 2020
DelMar Pharmaceuticals to Present Updates of Two Phase 2 Clinical Trials of VAL-083 at the 2020 American Association for Cancer Research Virtual Annual Meeting II
May 13, 2020
DelMar Pharmaceuticals Announces Fiscal Third Quarter 2020 Financial Results and Recent Corporate Updates
May 05, 2020
DelMar Pharmaceuticals [Nasdaq:DMPI] Provides Enrollment Update in Phase 2 Clinical Trial of VAL-083 for Adjuvant Treatment of Brain Tumors
Mar 26, 2020
DelMar Pharmaceuticals Receives Nasdaq Bid Price Extension
Mar 04, 2020
DelMar Pharmaceuticals [Nasdaq:DMPI] Reports Over 50% Enrollment in Phase 2 Clinical Trial of VAL-083 For Adjuvant Treatment of Brain Tumors
Feb 13, 2020
DelMar Pharmaceuticals Announces Fiscal Second Quarter 2020 Financial Results and Recent Corporate Updates
Feb 05, 2020
DelMar Pharmaceuticals to Attend the 22nd Annual BIO CEO & Investor Conference in New York City February 10 and 11, 2020
Jan 29, 2020
DelMar Pharmaceuticals Announces Peer-Reviewed Publication of Interim Results of Phase 2 Clinical Trial of VAL-083 As First-Line Treatment in Newly-Diagnosed MGMT-Unmethylated Glioblastoma Multiforme
Nov 05, 2019
DelMar Pharmaceuticals to Host Key Opinion Leader Summit on Glioblastoma Multiforme and the Potential for Treatment with VAL-083
Oct 29, 2019
DelMar Pharmaceuticals to Present Updates of Two Phase 2 Clinical Trials of VAL-083 at the 2019 Society for NeuroOncology Annual Meeting
Oct 24, 2019
DelMar Pharmaceuticals to Present on October 29th at the 5th Annual Dawson James Small Cap Growth Conference
Oct 10, 2019
DelMar Pharmaceuticals to Present at the Inaugural MicroCap Rodeo Investor Conference on October 15, 2019 at 11:30 AM Central Time
Sep 11, 2019
DelMar Pharmaceuticals to Present at the Fall Investor Summit on September 16, 2019
Sep 10, 2019
DelMar Pharmaceuticals Announces Fiscal Year 2019 Financial Results and Recent Corporate Updates
Sep 09, 2019
DelMar Pharmaceuticals Reports Full Compliance with Nasdaq Listing Criteria
Aug 27, 2019
DelMar Pharmaceuticals Anticipates Current Cash Runway Will Provide Sufficient Capital for Full Enrollment in All Three Patient Groups in Two Phase 2 Clinical Trials
Aug 14, 2019
DelMar Pharmaceuticals Announces Pricing Of $6.8 Million Underwritten Public Offering
  •  
  • Page 1
  • ››

Latest News

Aug 19, 2025

Vantage Data Centers Unveils Plans for “Frontier,” a $25B Mega-campus in Texas to Meet Unprecedented AI Demand

Aug 19, 2025

Wallbox Regains Compliance with NYSE Listing Standards

Aug 19, 2025

CORE Industrial Partners Announces New Platform Investment in IMMEC

Aug 19, 2025

Insulet to Participate in Upcoming Investor Conferences

Aug 19, 2025

RUX Acquires Open Door Technology and ERP Connect Consulting to Power Industry Built ERP Solutions for the...

Aug 19, 2025

Teqram Installs America’s First AI-Powered Grinding Robot at AMP

Aug 19, 2025

Chemours and SRF Limited Announce Strategic Agreements in India to Support Market Needs for Essential...

Aug 19, 2025

Castellum, Inc. and Tradewinds Networks, Inc. Announce Execution of Reseller Agreement

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia